Skin barrier dysfunction in AD patients has been related to proinflammatory cytokine production, mainly IL-4 and IL-13, that inhibits the expression of barrier-related molecules such as filaggrin, involucrin and loricrin, that damage the skin barrier. Here, IL4 is linked to Alzheimer disease.